These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19395498)

  • 21. [Diabetes and dyslipidemia].
    Fatati G
    Recenti Prog Med; 1999 Jan; 90(1):21-4. PubMed ID: 10193161
    [No Abstract]   [Full Text] [Related]  

  • 22. [Follow-up of the type 2 diabetic patient excluding follow-up of complications. Recommendations of ANAES].
    Diabetes Metab; 1999 Mar; 25 Suppl 2():1-64. PubMed ID: 10226757
    [No Abstract]   [Full Text] [Related]  

  • 23. Impaired glucose tolerance and unidentified diabetes.
    Heine RJ; Mooy JM
    Postgrad Med J; 1996 Feb; 72(844):67-71. PubMed ID: 8871454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B; Lund SS; Vaag A
    Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
    Weiss IA; Valiquette G; Schwarcz MD
    Cardiol Rev; 2009; 17(4):165-75. PubMed ID: 19525678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?
    Peter R; Reilly E; Anthony S
    Curr Opin Lipidol; 2010 Dec; 21(6):554-5. PubMed ID: 21206346
    [No Abstract]   [Full Text] [Related]  

  • 28. Glucose control in type 2 diabetes: still worthwhile and worth pursuing.
    Kahn SE
    JAMA; 2009 Apr; 301(15):1590-2. PubMed ID: 19366780
    [No Abstract]   [Full Text] [Related]  

  • 29. The importance of tight blood glucose control in diabetes.
    Andersson DK
    Scand J Prim Health Care; 1995 Jun; 13(2):81-2. PubMed ID: 7569482
    [No Abstract]   [Full Text] [Related]  

  • 30. Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes.
    Mazzone T
    J Lab Clin Med; 2000 Jun; 135(6):437-43. PubMed ID: 10850642
    [No Abstract]   [Full Text] [Related]  

  • 31. [Risk factors of microangiopathy in patients with non-insulin dependent diabetes mellitus].
    Czech A; Szczeklik Z; Przybyś W
    Pol Tyg Lek; 1996 Jan; 51(1-5):35-6. PubMed ID: 8754299
    [No Abstract]   [Full Text] [Related]  

  • 32. Coronary artery calcium: a clue to the enigma of tight glycemic control and cardiovascular disease?
    Bertoni AG; Kitzman DW
    Diabetes; 2009 Nov; 58(11):2448-9. PubMed ID: 19875621
    [No Abstract]   [Full Text] [Related]  

  • 33. Type 2 diabetes and cardiovascular risk factors.
    Sharma MD; Farmer JA; Garber A
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():1-5. PubMed ID: 22106974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and metabolic profile in diabetic cardiovascular disease.
    Vaishnava H; Hagroo AA
    J Indian Med Assoc; 1973 Aug; 61(4):159-66. PubMed ID: 4590355
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular disease in diabetics: pharmacology and revascularization.
    Mangalmurti SS; Farkouh ME
    Mt Sinai J Med; 2004 Nov; 71(6):375-83. PubMed ID: 15592656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycaemic control and macrovascular complications of type 2 diabetes.
    Dandona P; Chaudhuri A
    Natl Med J India; 2008; 21(6):271-4. PubMed ID: 19691214
    [No Abstract]   [Full Text] [Related]  

  • 37. Beyond the UKPDS: in search of the optimal strategy for the treatment of type 2 diabetes.
    Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Jun; 10(3):104-7. PubMed ID: 11006917
    [No Abstract]   [Full Text] [Related]  

  • 38. Dysglycaemia and risk of cardiovascular disease.
    Jarrett RJ
    Lancet; 1996 Jun; 347(9018):1833-4. PubMed ID: 8667944
    [No Abstract]   [Full Text] [Related]  

  • 39. [Should we prescribe regular physical activity for patients presenting with type 2 diabetes?].
    Gautier JF
    Diabete Metab; 1994; 20(5):497-500. PubMed ID: 7859899
    [No Abstract]   [Full Text] [Related]  

  • 40. Earlier treatment may explain diabetes data.
    Abbey DM
    Science; 2009 Feb; 323(5917):1009. PubMed ID: 19229018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.